Palisade bio announces inducement awards under inducement plan for key new hires

Carlsbad, calif., may 10, 2022 (globe newswire) -- palisade bio (nasdaq: pali), a clinical-stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, today announced that it had made equity grants to four new employees under its 2021 inducement plan.

PALI Ratings Summary

PALI Quant Ranking